Remove 2023 Remove Biopharmaceuticals Remove Collaboration
article thumbnail

BiBo Pharma: A Global CDMO Leading in Advanced Biopharmaceutical Manufacturing Technologies

Frost & Sullivan

In 2023, BiBo Pharma, founded in Boston, USA, introduced a new generation of ultra-large production platforms. BiBo Pharma is breaking capacity barriers and reducing antibody drug production costs from the international average of hundreds of dollars to just $10 per gram, offering disruptive solutions to global biopharmaceutical companies.

article thumbnail

Leadership in Biopharma: Key thought leaders in the Biopharma industry

Jake Jorgovan

His career highlights include igniting US reimbursement pathways for Prescription Digital Therapeutics (PDT), pioneering value-based collaboration between payers and manufacturers, and introducing groundbreaking biotech and healthtech solutions.

Biopharma 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Parexel Recognized with Frost & Sullivan’s 2023 North American Customer Value Leadership Award for Impactful Real-world Evidence Solutions Addressing Customer Needs

Frost & Sullivan

San Antonio, TX — December 19, 2023 — Frost & Sullivan today recognized Parexel , one of the world’s largest clinical research organizations (CROs), with the 2023 North American Customer Value Leadership Award following recent in-depth research of the Real-world Evidence (RWE) services industry.

article thumbnail

Emmes Applauded by Frost & Sullivan for Streamlining Clinical Trials and for Its Competitive Strategies

Frost & Sullivan

April 25, 2023 – Frost & Sullivan researched the contract research organizations industry and, based on its analysis results, recognizes Emmes with the 2023 Global Competitive Strategy Leadership Award. SAN ANTONIO, TX. The company’s clients include numerous agencies and institutes of the U.S.